The size of the Vascular Stent Market in the Middle East & Africa has been estimated at USD 1.80 billion in 2022. It is projected to be growing at a CAGR of 8.9% and worth USD 2.75 billion by 2027.
A stent is an expandable and tiny mesh made of metals or polymers. An implanted stent stays in the artery permanently, although a blocked stent can be removed by an angiography procedure.
The main purpose of a vascular stent is to provide support in keeping the clogged artery open which leads to a better and increased blood flow to the heart. The unclogged arteries and increased blood flow substantively reduce the probability of a heart attack.
The growth of the Middle East and Africa Vascular Stent Market is driven by the increasing use of vascular stents for cardiovascular diseases. This is further supplemented by the increasing preference for stents over other outdated methods which were relatively more invasive. The rising elderly populace in the Middle-East and Africa with the consequently increasing incidence of CVDs is also a major sponsor of market growth in the region.
The restraints faced by the market include the stern regulation guidelines by governmental bodies and a rising number of cases of product failure and recalls.
This research report on the Middle East and Africa Vascular Stent Market has been segmented and sub-segmented into the following categories.
By Product:
By Type:
By Mode of Delivery:
By Material:
By End User:
By Country:
Companies that have presence in the Middle East & Africa Vascular Stent Market profiled in the report are Medtronic, plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), W. L. Gore and Associates (U.S.), C. R. Bard (U.S.), Endologix, Inc. (U.S.), Lombard Medical Technologies (U.K.), Translumina GmbH (Germany), and JOTEC GmbH (Germany).
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Coronary Stents
5.1.3 Peripheral Stents
5.1.3.1 Carotid Artery Stents
5.1.3.2 Renal Artery Stents
5.1.3.3 Femoral Artery Stents
5.1.3.4 Illiac Artery Stents
5.1.3.5 Other Peripheral Stents
5.1.4 EVAR Stent Grafts
5.1.4.1 Abdominal Aortic Aneurysm Stents
5.1.4.2 Thoracic Aortic Aneurysm Stents
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Type
5.2.1 Introduction
5.2.2 Drug-Eluting Stents
5.2.3 Bare Metal Stents
5.2.4 Bioabsorbable Stents
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3 Mode of Delivery
5.3.1 Introduction
5.3.2 Balloon Expandable Stents
5.3.3 Self-Expanding Stents
5.3.4 Y-o-Y Growth Analysis, By Mode of Delivery
5.3.5 Market Attractiveness Analysis, By Mode of Delivery
5.3.6 Market Share Analysis, By Mode of Delivery
5.4 Material
5.4.1 Introduction
5.4.2 Metallic Stents
5.4.2.1 Cobalt Chromium
5.2.4.2 Platinum Chromium
5.2.4.3 Nickel Titanium
5.2.4.4 Stainless Steel
5.4.3 Polymer Stents
5.4.4 Other materials
5.4.4 Y-o-Y Growth Analysis, By Material
5.4.5 Market Attractiveness Analysis, By Material
5.4.6 Market Share Analysis, By Material
5.5 End User
5.5.1 Introduction
5.5.2 Hospitals and Surgical Centers
5.5.3 Research Institutes
5.5.4 Y-o-Y Growth Analysis, By End User
5.5.5 Market Attractiveness Analysis, By End User
5.5.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type
6.1.3.4 By Mode of Delivery
6.1.3.5 By Material
6.1.3.6 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type
6.1.4.4 By Mode of Delivery
6.1.4.5 By Material
6.1.4.6 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type
6.1.5.4 By Mode of Delivery
6.1.5.5 By Material
6.1.5.6 By End User
6.2 Middle-East
6.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Medtronic Plc
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Abbott Laboratories
8.3 Boston Scientific Corporation
8.4 Biotronik Se & Co, Kg
8.5 B. Braun Melsungen Ag
8.6 Terumo Corporation
8.7 Microsoft Scientific Corporation
8.8 Meril Life Sciences
8.9 Vascular Concepts Limited
8.10 C.R Bard
8.11 W.L Gore and Associates
8.12 Endologix
8.13 Lombard Medical
8.14 Translumina Gmbh
8.15 Jotec Gmbh
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
